Interlaboratory Study for Characterizing Monoclonal Antibodies by Top-Down and Middle-Down Mass Spectrometry
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
The Consortium for Top-Down Proteomics (www.topdownproteomics.org) launched the present study to assess the current state of top-down mass spectrometry (TD MS) and middle-down mass spectrometry (MD MS) for characterizing monoclonal antibody (mAb) primary structures, including their modifications. To meet the needs of the rapidly growing therapeutic antibody market, it is important to develop analytical strategies to characterize the heterogeneity of a therapeutic product's primary structure accurately and reproducibly. The major objective of the present study is to determine whether current TD/MD MS technologies and protocols can add value to the more commonly employed bottom-up (BU) approaches with regard to confirming protein integrity, sequencing variable domains, avoiding artifacts, and revealing modifications and their locations. We also aim to gather information on the common TD/MD MS methods and practices in the field. A panel of three mAbs was selected and centrally provided to 20 laboratories worldwide for the analysis: Sigma mAb standard (SiLuLite), NIST mAb standard, and the therapeutic mAb Herceptin (trastuzumab). Various MS instrument platforms and ion dissociation techniques were employed. The present study confirms that TD/MD MS tools are available in laboratories worldwide and provide complementary information to the BU approach that can be crucial for comprehensive mAb characterization. The current limitations, as well as possible solutions to overcome them, are also outlined. A primary limitation revealed by the results of the present study is that the expert knowledge in both experiment and data analysis is indispensable to practice TD/MD MS.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry
Syka, J. E. P., Coon, J. J., Schroeder, M. J., Shabanowitz, J., & Hunt, D. F. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402700101 · Cited by 2,370
Self-citationProteoform: a single term describing protein complexity
The Consortium for Top Down Proteomics, Smith, L. M., & Kelleher, N. L. (2013) · Nature Methods · doi:10.1038/nmeth.2369 · Cited by 1,528
Self-citationInterpretation of Shotgun Proteomic Data
Nesvizhskii, A. I., & Aebersold, R. (2005) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r500012-mcp200 · Cited by 1,025
Marty, M. T., Baldwin, A. J., Marklund, E. G., Hochberg, G. K. A., Benesch, J. L. P., & Robinson, C. V. (2015) · Analytical Chemistry · doi:10.1021/acs.analchem.5b00140 · Cited by 1,000
Biopharmaceutical benchmarks 2018
Walsh, G. (2018) · Nature Biotechnology · doi:10.1038/nbt.4305 · Cited by 978
How many human proteoforms are there?
Aebersold, R., Agar, J. N., Amster, I. J., Baker, M. S., Bertozzi, C. R., Boja, E. S., Costello, C. E., Cravatt, B. F., Fenselau, C., Garcia, B. A., et al. (2018) · Nature Chemical Biology · doi:10.1038/nchembio.2576 · Cited by 907
Self-citationProgress in Top-Down Proteomics and the Analysis of Proteoforms
Toby, T. K., Fornelli, L., & Kelleher, N. L. (2016) · Annual Review of Analytical Chemistry · doi:10.1146/annurev-anchem-071015-041550 · Cited by 576
Self-citationAutomated reduction and interpretation of
Horn, D. M., Zubarev, R. A., & McLafferty, F. W. (2000) · Journal of the American Society for Mass Spectrometry · doi:10.1016/s1044-0305(99)00157-9 · Cited by 507
ChemCalc: A building block for tomorrow’s chemical infrastructure
Patiny, L., & Borel, A. (2013) · Journal of Chemical Information and Modeling · doi:10.1021/ci300563h · Cited by 425
Best practices and benchmarks for intact protein analysis for top-down mass spectrometry
Donnelly, D. P., Rawlins, C. M., DeHart, C. J., Fornelli, L., Schachner, L. F., Lin, Z., Lippens, J. L., Aluri, K. C., Sarin, R., Chen, B., et al. (2019) · Nature Methods · doi:10.1038/s41592-019-0457-0 · Cited by 377
Self-citationExtending Top-Down Mass Spectrometry to Proteins with Masses Greater Than 200 Kilodaltons
Han, X., Jin, M., Breuker, K., & McLafferty, F. W. (2006) · Science · doi:10.1126/science.1128868 · Cited by 328
ProSight Lite: Graphical software to analyze top‐down mass spectrometry data
Fellers, R. T., Greer, J. B., Early, B. P., Yu, X., LeDuc, R. D., Kelleher, N. L., & Thomas, P. M. (2015) · PROTEOMICS · doi:10.1002/pmic.201400313 · Cited by 247
Self-citationRogers, R. S., Nightlinger, N. S., Livingston, B., Campbell, P., Bailey, R., & Balland, A. (2015) · mAbs · doi:10.1080/19420862.2015.1069454 · Cited by 231
Fornelli, L., Srzentić, K., Huguet, R., Mullen, C., Sharma, S., Zabrouskov, V., Fellers, R. T., Durbin, K. R., Compton, P. D., & Kelleher, N. L. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b00984 · Cited by 150
Self-citationLermyte, F., Tsybin, Y. O., O’Connor, P. B., & Loo, J. A. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-019-02201-x · Cited by 132
Self-citationMASH Suite Pro: A Comprehensive Software Tool for Top-Down Proteomics
Cai, W., Guner, H., Gregorich, Z. R., Chen, A. J., Ayaz-Guner, S., Peng, Y., Valeja, S. G., Liu, X., & Ge, Y. (2016) · Molecular & Cellular Proteomics · doi:10.1074/mcp.o115.054387 · Cited by 132
Self-citationToward an Optimized Workflow for Middle-Down Proteomics
Cristobal, A., Marino, F., Post, H., van den Toorn, H. W. P., Mohammed, S., & Heck, A. J. R. (2017) · Analytical Chemistry · doi:10.1021/acs.analchem.6b03756 · Cited by 130
Multi‐Attribute Method for Quality Control of Therapeutic Proteins
Rogstad, S., Yan, H., Wang, X., Powers, D., Brorson, K., Damdinsuren, B., & Lee, S. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03808 · Cited by 123
Fornelli, L., Durbin, K. R., Fellers, R. T., Early, B. P., Greer, J. B., LeDuc, R. D., Compton, P. D., & Kelleher, N. L. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.6b00698 · Cited by 88
Self-citationShaw, J. B., Liu, W., Vasil′ev, Y. V., Bracken, C. C., Malhan, N., Guthals, A., Beckman, J. S., & Voinov, V. G. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.9b03129 · Cited by 77
Self-citationJin, Y., Lin, Z., Xu, Q., Fu, C., Zhang, Z., Zhang, Q., Pritts, W. A., & Ge, Y. (2019) · mAbs · doi:10.1080/19420862.2018.1525253 · Cited by 68
Self-citationValeja, S. G., Kaiser, N. K., Xian, F., Hendrickson, C. L., Rouse, J. C., & Marshall, A. G. (2011) · Analytical Chemistry · doi:10.1021/ac202429c · Cited by 67
Self-citationUgrin, S. A., English, A. M., Syka, J. E. P., Bai, D. L., Anderson, L. C., Shabanowitz, J., & Hunt, D. F. (2019) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-019-02290-8 · Cited by 44
Self-citationMiddle-Down Multi-Attribute Analysis of Antibody-Drug Conjugates with Electron Transfer Dissociation
Chen, B., Lin, Z., Zhu, Y., Jin, Y., Larson, E., Xu, Q., Fu, C., Zhang, Z., Zhang, Q., Pritts, W. A., et al. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b02194 · Cited by 38
Self-citationExtending the Isotopically Resolved Mass Range of Orbitrap Mass Spectrometers
Shaw, J. B., & Brodbelt, J. S. (2013) · Analytical Chemistry · doi:10.1021/ac401634b · Cited by 28
Self-citation
Research works printed but not linked: 82
- Beck, 2019, Macro- and Micro-Heterogeneity of Natural and Recombinant IgG Antibodies, Antibodies, 8, 18, 10.3390/antib8010018 · DOI
- Rathore, 2018, The role of mass spectrometry in the characterization of biologic protein products, Expert Rev. Proteomics, 15, 431, 10.1080/14789450.2018.1469982 · DOI · Paper page
- Taussig, 2018, Antibody validation: a view from the mountains, New Biotechnol., 45, 1, 10.1016/j.nbt.2018.08.002 · DOI · Paper page
- Rogers, 2018, A View on the Importance of "Multi-Attribute Method" for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy, AAPS J., 20, 7, 10.1208/s12248-017-0168-3 · DOI · Paper page
- Xu, 2017, A Quadrupole Dalton-based multi-attribute method for product characterization, process development, and quality control of therapeutic proteins, mAbs., 9, 1186, 10.1080/19420862.2017.1364326 · DOI · Paper page
- Grilo, 2019, The Increasingly Human and Profitable Monoclonal Antibody Market, Trends Biotechnol., 37, 9, 10.1016/j.tibtech.2018.05.014 · DOI · Paper page
- Duivelshof, 2019, Glycosylation of biosimilars: Recent advances in analytical characterization and clinical implications, Anal. Chim. Acta, 1089, 1, 10.1016/j.aca.2019.08.044 · DOI
- Kaplon, 2020, Antibodies to watch in 2020, mAbs., 12, 1703531, 10.1080/19420862.2019.1703531 · DOI · Paper page
- Xu, 2019, Structure, heterogeneity and developability assessment of therapeutic antibodies, mAbs., 11, 239, 10.1080/19420862.2018.1553476 · DOI · Paper page
- Nowak, 2017, Forced degradation of recombinant monoclonal antibodies: A practical guide, mAbs, 9, 1217, 10.1080/19420862.2017.1368602 · DOI · Paper page
- Ebbers, 2012, Interchangeability, immunogenicity and biosimilars, Nat. Biotechnol., 30, 1186, 10.1038/nbt.2438 · doi:10.1038/nbt.2438
- Rogstad, 2017, A Retrospective Evaluation of the Use of Mass Spectrometry in FDA Biologics License Applications, J. Am. Soc. Mass Spectrom., 28, 786, 10.1007/s13361-016-1531-9 · DOI · Paper page
- Ambrogelly, 2018, Analytical comparability study of recombinant monoclonal antibody therapeutics, mAbs., 10, 513, 10.1080/19420862.2018.1438797 · DOI
- Fornelli, 2018, Top-down proteomics: Where we are, where we are going?, J. Proteomics, 175, 3, 10.1016/j.jprot.2017.02.002 · DOI
- Boutz, 2014, Proteomic Identification of Monoclonal Antibodies from Serum, Anal. Chem., 86, 4758, 10.1021/ac4037679 · DOI
- Miller, 2019, Improved Protein Inference from Multiple Protease Bottom-Up Mass Spectrometry Data, Journal of Proteome Research., 18, 3429, 10.1021/acs.jproteome.9b00330 · DOI
- Cheung, 2012, A proteomics approach for the identification and cloning of monoclonal antibodies from serum, Nat. Biotechnol., 30, 447, 10.1038/nbt.2167 · DOI · Paper page
- Srzentić, 2018, Chemical-Mediated Digestion: An Alternative Realm for Middle-down Proteomics?, Journal of Proteome Research., 17, 2005, 10.1021/acs.jproteome.7b00834 · DOI
- Srzentić, 2014, Advantages of extended bottom-up proteomics using Sap9 for analysis of monoclonal antibodies, Anal. Chem., 86, 9945, 10.1021/ac502766n · DOI
- McLafferty, 2007, Top-down MS, a powerful complement to the high capabilities of proteolysis proteomics, FEBS J., 274, 6256, 10.1111/j.1742-4658.2007.06147.x · DOI · Paper page
- Sen, 2017, Automated antibody de novo sequencing and its utility in biopharmaceutical discovery, J. Am. Soc. Mass Spectrom., 28, 803, 10.1007/s13361-016-1580-0 · DOI
- Morsa, 2019, Multi-Enzymatic Limited Digestion: The Next-Generation Sequencing for Proteomics?, Journal of Proteome Research., 18, 2501, 10.1021/acs.jproteome.9b00044 · DOI
- Müller, 2017, Systematic Evaluation of Protein Reduction and Alkylation Reveals Massive Unspecific Side Effects by Iodine-containing Reagents, Mol. Cell. Proteomics, 16, 1173, 10.1074/mcp.M116.064048 · DOI · Paper page
- Resemann, 2016, Full validation of therapeutic antibody sequences by middle-up mass measurements and middle-down protein sequencing, mAbs., 8, 318, 10.1080/19420862.2015.1128607 · DOI
- Loo, 1990, Primary sequence information from intact proteins by electrospray ionization tandem mass spectrometry, Science, 248, 201, 10.1126/science.2326633 · DOI · Paper page
- Loo, 1991, Tandem mass spectrometry of very large molecules: serum albumin sequence information from multiply charged ions formed by electrospray ionization, Anal. Chem., 63, 2488, 10.1021/ac00021a018 · DOI · Paper page
- McLafferty, 2001, Electron capture dissociation of gaseous multiply charged ions by Fourier transform ion cyclotron resonance, J. Am. Soc. Mass Spectrom., 12, 245, 10.1016/S1044-0305(00)00223-3 · DOI · Paper page
- Brodbelt, 2014, Photodissociation mass spectrometry: new tools for characterization of biological molecules, Chem. Soc. Rev., 43, 2757, 10.1039/C3CS60444F · DOI · Paper page
- Demeure, 2007, Rational Selection of the Optimum MALDI Matrix for Top-Down Proteomics by In-Source Decay, Anal. Chem., 79, 8678, 10.1021/ac070849z · DOI
- Fukuyama, 2006, Rapid sequencing and disulfide mapping of peptides containing disulfide bonds by using 1,5-diaminonaphthalene as a reductive matrix, J. Mass Spectrom., 41, 191, 10.1002/jms.977 · DOI
- LeDuc, 2007, Using ProSight PTM and Related Tools for Targeted Protein Identification and Characterization with High Mass Accuracy Tandem MS Data, Current Protocols in Bioinformatics., 19, 13.16.11, 10.1002/0471250953.bi1306s19 · DOI · Paper page
- Smith, 2019, A five-level classification system for proteoform identifications, Nat. Methods, 16, 939, 10.1038/s41592-019-0573-x · DOI · Paper page
- Park, 2017, Informed-Proteomics: open-source software package for top-down proteomics, Nat. Methods, 14, 909, 10.1038/nmeth.4388 · DOI · Paper page
- Tsybin, 2011, Structural analysis of intact monoclonal antibodies by electron transfer dissociation mass spectrometry, Anal. Chem., 83, 8919, 10.1021/ac201293m · DOI · Paper page
- Mao, 2013, Top-down structural analysis of an intact monoclonal antibody by electron capture dissociation Fourier transform ion cyclotron resonance mass spectrometry, Anal. Chem., 85, 4239, 10.1021/ac303525n · DOI · Paper page
- Fornelli, 2017, Top-down analysis of immunoglobulin G isotypes 1 and 2 with electron transfer dissociation on a high-field Orbitrap mass spectrometer, J. Proteomics, 159, 67, 10.1016/j.jprot.2017.02.013 · DOI · Paper page
- Fornelli, 2012, Analysis of intact monoclonal antibody IgG1 by electron transfer dissociation Orbitrap FTMS, Mol. Cell. Proteomics, 11, 1758, 10.1074/mcp.M112.019620 · DOI · Paper page
- Shaw, 2018, Sequencing grade tandem mass spectrometry for top-down proteomics using hybrid electron capture dissociation methods in a benchtop Orbitrap mass spectrometer, Anal. Chem., 90, 10819, 10.1021/acs.analchem.8b01901 · DOI · Paper page
- Zhang, 2009, Mass spectrometry for structural characterization of therapeutic antibodies, Mass Spectrom. Rev., 28, 147, 10.1002/mas.20190 · DOI · Paper page
- Wang, 2013, Structural comparison of two anti-CD20 monoclonal antibody drug products using middle-down mass spectrometry, Analyst, 138, 3058, 10.1039/c3an36524g · DOI
- Bondarenko, 2009, Mass measurement and top-down HPLC/MS analysis of intact monoclonal antibodies on a hybrid linear quadrupole ion trap–Orbitrap mass spectrometer, J. Am. Soc. Mass Spectrom., 20, 1415, 10.1016/j.jasms.2009.03.020 · DOI · Paper page
- Ayoub, 2013, Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques, mAbs., 5, 699, 10.4161/mabs.25423 · DOI · Paper page
- Fornelli, 2014, Middle-Down Analysis of Monoclonal Antibodies with Electron Transfer Dissociation Orbitrap Fourier Transform Mass Spectrometry, Anal. Chem., 86, 3005, 10.1021/ac4036857 · DOI · Paper page
- Srzentić, 2018, Multiplexed Middle-Down Mass Spectrometry as a Method for Revealing Light and Heavy Chain Connectivity in a Monoclonal Antibody, Anal. Chem., 90, 12527, 10.1021/acs.analchem.8b02398 · DOI · Paper page
- Cotham, 2016, Characterization of Therapeutic Monoclonal Antibodies at the Subunit-Level using Middle-Down 193 nm Ultraviolet Photodissociation, Anal. Chem., 88, 4004, 10.1021/acs.analchem.6b00302 · DOI · Paper page
- Laskay, 2014, Extended bottom-up proteomics with secreted aspartic protease Sap9, J. Proteomics, 110, 20, 10.1016/j.jprot.2014.07.035 · DOI
- Sjögren, 2017, Generating and Purifying Fab Fragments from Human and Mouse IgG Using the Bacterial Enzymes IdeS, SpeB and Kgp, 10.1007/978-1-4939-6673-8_21 · DOI
- Faid, 2018, Middle-up analysis of monoclonal antibodies after combined IgdE and IdeS hinge proteolysis: Investigation of free sulfhydryls, J. Pharm. Biomed. Anal., 149, 541, 10.1016/j.jpba.2017.11.046 · DOI
- Brunner, 2015, Benchmarking Multiple Fragmentation Methods on an Orbitrap Fusion for Top-down Phospho-Proteoform Characterization, Anal. Chem., 87, 4152, 10.1021/acs.analchem.5b00162 · DOI · Paper page
- Fornelli, 2013, Top-down analysis of 30–80 kDa proteins by electron transfer dissociation time-of-flight mass spectrometry, Anal. Bioanal. Chem., 405, 8505, 10.1007/s00216-013-7267-5 · DOI
- Bakalarski, 2016, Rapid, semi-automated protein terminal characterization using ISDetect, Nat. Biotechnol., 34, 811, 10.1038/nbt.3621 · DOI
- De Leoz, M. L. A.; Duewer, D. L.; Stein, S. E. NIST Interlaboratory Study on the Glycosylation of NIST mAb, a Monoclonal Antibody Reference Material, June 2015 to February 2016, NISTIR 8186; NIST, 2017. 10.6028/NIST.IR.8186. · doi:10.6028/nist.ir.8186
- Li, 2017, Global Post-Translational Modification Discovery, Journal of Proteome Research., 16, 1383, 10.1021/acs.jproteome.6b00034 · DOI · Paper page
- Farrell, 2018, Monoclonal antibody sequence assessment using a hybrid quadrupole-Orbitrap mass spectrometer, Anal. Methods, 10, 3100, 10.1039/C8AY00582F · DOI
- Lössl, 2014, Boundaries of Mass Resolution in Native Mass Spectrometry, J. Am. Soc. Mass Spectrom., 25, 906, 10.1007/s13361-014-0874-3 · DOI · Paper page
- Jennewein, 2017, The Immunoregulatory Roles of Antibody Glycosylation, Trends Immunol., 38, 358, 10.1016/j.it.2017.02.004 · DOI · Paper page
- Wei, 2017, Glycation of antibodies: Modification, methods and potential effects on biological functions, mAbs., 9, 586, 10.1080/19420862.2017.1300214 · DOI · Paper page
- Li, 2015, Structural Elucidation of Post-Translational Modifications in Monoclonal Antibodies, 10.1021/bk-2015-1201.ch003 · DOI
- van der Burgt, 2019, Structural Analysis of Monoclonal Antibodies by Ultrahigh Resolution MALDI In-Source Decay FT-ICR Mass Spectrometry, Anal. Chem., 91, 2079, 10.1021/acs.analchem.8b04515 · DOI
- Nallet, 2012, Glycan variability on a recombinant IgG antibody transiently produced in HEK-293E cells, New Biotechnol., 29, 471, 10.1016/j.nbt.2012.02.003 · DOI
- Gstöttner, 2020, Monitoring glycation levels of a bispecific monoclonal antibody at subunit level by ultrahigh-resolution MALDI FT-ICR mass spectrometry, mAbs., 12, 1682403, 10.1080/19420862.2019.1682403 · DOI
- Tyshchuk, 2019, Characterization and prediction of positional 4-hydroxyproline and sulfotyrosine, two post-translational modifications that can occur at substantial levels in CHO cells-expressed biotherapeutics, mAbs, 11, 1219, 10.1080/19420862.2019.1635865 · DOI
- Tran, 2016, Complete De Novo Assembly of Monoclonal Antibody Sequences, Sci. Rep., 6, 31730, 10.1038/srep31730 · DOI · Paper page
- Wu, 2009, An Integrated Top-Down and Bottom-Up Strategy for Broadly Characterizing Protein Isoforms and Modifications, Journal of Proteome Research., 8, 1347, 10.1021/pr800720d · DOI · Paper page
- He, 2019, Classification of Plasma Cell Disorders by 21 T Fourier Transform Ion Cyclotron Resonance Top-Down and Middle-Down MS/MS Analysis of Monoclonal Immunoglobulin Light Chains in Human Serum, Anal. Chem., 91, 3263, 10.1021/acs.analchem.8b03294 · DOI
- Sjögren, 2015, EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans, Glycobiology, 25, 1053, 10.1093/glycob/cwv047 · DOI
- Plomp, 2015, Hinge-Region O-Glycosylation of Human Immunoglobulin G3 (IgG3), Mol. Cell. Proteomics, 14, 1373, 10.1074/mcp.M114.047381 · DOI
- Zauner, 2013, Glycoproteomic Analysis of Antibodies, Mol. Cell. Proteomics, 12, 856, 10.1074/mcp.R112.026005 · DOI · Paper page
- Lyon, 2018, The Ups and Downs of Repeated Cleavage and Internal Fragment Production in Top-Down Proteomics, J. Am. Soc. Mass Spectrom., 29, 150, 10.1007/s13361-017-1823-8 · DOI · Paper page
- Zenaidee, M. A.; Lantz, C.; Perkins, T.; Jung, W.; Ogorzalek Loo, R. R.; Loo, J. A. Internal Fragments Generated by Electron Ionization Dissociation Enhance Protein Top-Down Mass Spectrometry. J. Am. Soc. Mass Spectrom., 2020 in press (https://doi.org/10.1021/jasms.0c00160). · doi:10.26434/chemrxiv.11573337.v2
- Huang, 2010, Top-down protein characterization facilitated by ion/ion reactions on a quadrupole/time of flight platform, Proteomics, 10, 3577, 10.1002/pmic.201000187 · DOI
- Riley, 2015, Activated Ion Electron Transfer Dissociation for Improved Fragmentation of Intact Proteins, Anal. Chem., 87, 7109, 10.1021/acs.analchem.5b00881 · DOI · Paper page
- Giorgetti, 2020, Combination of intact, middle-up and bottom-up levels to characterize 7 therapeutic monoclonal antibodies by capillary electrophoresis – mass spectrometry, J. Pharm. Biomed. Anal., 182, 113107, 10.1016/j.jpba.2020.113107 · DOI
- Lermyte, 2019, MIND: A Double-Linear Model To Accurately Determine Monoisotopic Precursor Mass in High-Resolution Top-Down Proteomics, Anal. Chem., 91, 10310, 10.1021/acs.analchem.9b02682 · DOI
- Vyatkina, 2016, Top-down analysis of protein samples by de novo sequencing techniques, Bioinformatics, 32, 2753, 10.1093/bioinformatics/btw307 · DOI
- Zhou, 2015, Performance metrics for evaluating system suitability in liquid chromatographyMass spectrometry peptide mass mapping of protein therapeutics and monoclonal antibodies, mAbs., 7, 1104, 10.1080/19420862.2015.1074364 · DOI
- Florio, 2018, Recent Advances and Ongoing Challenges in the Diagnosis of Microbial Infections by MALDI-TOF Mass Spectrometry, Front. Microbiol., 10.3389/fmicb.2018.01097 · DOI
- Zhou, 2014, Surface Induced Dissociation: Dissecting Noncovalent Protein Complexes in the Gas phase, Acc. Chem. Res., 47, 1010, 10.1021/ar400223t · DOI · Paper page
- Di Stefano, 2018, Size-Dependent Hydrogen Atom Attachment to Gas-Phase Hydrogen-Deficient Polypeptide Radical Cations, J. Am. Chem. Soc., 140, 531, 10.1021/jacs.7b10318 · doi:10.1021/jacs.7b10318
- Beck, 2019, Cutting-edge multi-level analytical and structural characterization of antibody-drug conjugates: present and future, Expert Rev. Proteomics, 16, 337, 10.1080/14789450.2019.1578215 · DOI
- Hernandez-Alba, 2019, A Case Study to Identify the Drug Conjugation Site of a Site-Specific Antibody-Drug-Conjugate Using Middle-Down Mass Spectrometry, J. Am. Soc. Mass Spectrom., 30, 2419, 10.1007/s13361-019-02296-2 · DOI
- Watts, 2020, Comprehensive Middle-Down Mass Spectrometry Characterization of an Antibody–Drug Conjugate by Combined Ion Activation Methods, Anal. Chem., 92, 9790, 10.1021/acs.analchem.0c01232 · DOI
Cited by
Protein oxidation - Formation mechanisms, detection and relevance as biomarkers in human diseases
Kehm, R., Baldensperger, T., Raupbach, J., & Höhn, A. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101901 · Cited by 348
Roberts, D. S., Loo, J. A., Tsybin, Y. O., Liu, X., Wu, S., Chamot-Rooke, J., Agar, J. N., Paša-Tolić, L., Smith, L. M., & Ge, Y. (2024) · Nature Reviews Methods Primers · doi:10.1038/s43586-024-00318-2 · Cited by 161
Self-citationClipsMS: An Algorithm for Analyzing Internal Fragments Resulting from Top-Down Mass Spectrometry
(2021) · doi:10.1021/acs.jproteome.0c00952 · Cited by 72
Metadata
- Authors
- Srzentić, K., Fornelli, L., Tsybin, Y. O., Loo, J. A., Seckler, H., Agar, J. N., Anderson, L. C., Bai, D. L., Beck, A., Brodbelt, J. S., van der Burgt, Y. E. M., Chamot-Rooke, J., Chatterjee, S., Chen, Y., Clarke, D. J., Danis, P. O., Diedrich, J. K., D’Ippolito, R. A., Dupré, M., Gasilova, N., Ge, Y., Goo, Y. A., Goodlett, D. R., Greer, S., Haselmann, K. F., He, L., Hendrickson, C. L., Hinkle, J. D., Holt, M. V., Hughes, S., Hunt, D. F., Kelleher, N. L., Kozhinov, A. N., Lin, Z., Malosse, C., Marshall, A. G., Menin, L., Millikin, R. J., Nagornov, K. O., Nicolardi, S., Paša-Tolić, L., Pengelley, S., Quebbemann, N. R., Resemann, A., Sandoval, W., Sarin, R., Schmitt, N. D., Shabanowitz, J., Shaw, J. B., Shortreed, M. R., Smith, L. M., Sobott, F., Suckau, D., Toby, T., Weisbrod, C. R., Wildburger, N. C., Yates, J. R., Yoon, S. H., Young, N. L., & Zhou, M.
- Venue
- Journal of the American Society for Mass Spectrometry
- Publisher
- American Chemical Society (ACS)
- Published
- 2020-07-31
- Volume
- 31
- Issue
- 9
- Pages
- 1783-1802
- ISSN
- 1044-0305 (ISSN-L)
- 1879-1123
- OpenAlex
- W3046609539
- Cited by
- 116
- References
- 25
- FWCI
- 5.81
- Type
- journal article
- Language
- en
- Open access
- green
- Licence
- Funders
- Division of Chemistry (CHE1402753)
- Welch Foundation (F-1155)
- National Center for Research Resources (S10RR028893)
- Thermo Fisher Scientific
- NIH Office of the Director (S10 OD018504)
- H2020 Future and Emerging Technologies (829157)
- National Institute of General Medical Sciences (GM037537, GM108569, R01GM103479)
- Bruker Corporation
- Genovis AB
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.